Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5

Erectile dysfunction (ED) is a pathology that affects both an individual’s life and their partner’s, representing an increasing health concern. Currently, phosphodiesterase type 5 inhibitors (PDE5i) remain the first-line therapy for erectile dysfunction, and no other drugs are approved. However, the...

Full description

Bibliographic Details
Main Authors: Chiara Amante, Chiara De Soricellis, Gianni Luccheo, Anna Di Vernieri, Luigi Luccheo, Giovanni Falcone, Pasquale Del Gaudio
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/13/22/12358
_version_ 1827640624985145344
author Chiara Amante
Chiara De Soricellis
Gianni Luccheo
Anna Di Vernieri
Luigi Luccheo
Giovanni Falcone
Pasquale Del Gaudio
author_facet Chiara Amante
Chiara De Soricellis
Gianni Luccheo
Anna Di Vernieri
Luigi Luccheo
Giovanni Falcone
Pasquale Del Gaudio
author_sort Chiara Amante
collection DOAJ
description Erectile dysfunction (ED) is a pathology that affects both an individual’s life and their partner’s, representing an increasing health concern. Currently, phosphodiesterase type 5 inhibitors (PDE5i) remain the first-line therapy for erectile dysfunction, and no other drugs are approved. However, the high cost of these drugs and related adverse events limit their use. Since the concept of nutraceuticals has been extended from health promotion to the treatment of diseases, in this work, a novel mixture of different natural substances named Icarifil (L-Citrulline, L-Carnitine, <i>Eruca vesicaria</i>, <i>Panax ginseng</i>, <i>Tribulus terrestris</i>, <i>Turnera diffusa</i>, Taurine, Vitamin E, Zinc) was studied to verify its ability to increase the proliferation of muscle epithelium cells and cell turgor, as well as, due to containing antioxidants, its ability to reduce the amount of ROS that are mediators in the pathophysiological process of ED. Moreover, Icarifil showed efficacy in inhibiting PDE5 levels higher than 65% compared to the control and 35% compared to the mixture of L-Citrulline and L-Carnitine, the major components of the formulation. In association with the low dosage of a phosphodiesterase (PDE) inhibitor (tadalafil), the inhibitory capacity of tadalafil was significantly increased and comparable to high-dosage drug response, promoting the possibility of reducing the daily dosage of the drug and consequently its adverse effects.
first_indexed 2024-03-09T17:03:14Z
format Article
id doaj.art-25a556ce418c4e92af9e30a9447286fd
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-09T17:03:14Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-25a556ce418c4e92af9e30a9447286fd2023-11-24T14:27:25ZengMDPI AGApplied Sciences2076-34172023-11-0113221235810.3390/app132212358Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5Chiara Amante0Chiara De Soricellis1Gianni Luccheo2Anna Di Vernieri3Luigi Luccheo4Giovanni Falcone5Pasquale Del Gaudio6Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, ItalyDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, ItalyAnvest Health S.r.l., Via Rosario Livatino, 84083 Castel San Giorgio, ItalyAnvest Health S.r.l., Via Rosario Livatino, 84083 Castel San Giorgio, ItalyAnvest Health S.r.l., Via Rosario Livatino, 84083 Castel San Giorgio, ItalyDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, ItalyDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, ItalyErectile dysfunction (ED) is a pathology that affects both an individual’s life and their partner’s, representing an increasing health concern. Currently, phosphodiesterase type 5 inhibitors (PDE5i) remain the first-line therapy for erectile dysfunction, and no other drugs are approved. However, the high cost of these drugs and related adverse events limit their use. Since the concept of nutraceuticals has been extended from health promotion to the treatment of diseases, in this work, a novel mixture of different natural substances named Icarifil (L-Citrulline, L-Carnitine, <i>Eruca vesicaria</i>, <i>Panax ginseng</i>, <i>Tribulus terrestris</i>, <i>Turnera diffusa</i>, Taurine, Vitamin E, Zinc) was studied to verify its ability to increase the proliferation of muscle epithelium cells and cell turgor, as well as, due to containing antioxidants, its ability to reduce the amount of ROS that are mediators in the pathophysiological process of ED. Moreover, Icarifil showed efficacy in inhibiting PDE5 levels higher than 65% compared to the control and 35% compared to the mixture of L-Citrulline and L-Carnitine, the major components of the formulation. In association with the low dosage of a phosphodiesterase (PDE) inhibitor (tadalafil), the inhibitory capacity of tadalafil was significantly increased and comparable to high-dosage drug response, promoting the possibility of reducing the daily dosage of the drug and consequently its adverse effects.https://www.mdpi.com/2076-3417/13/22/12358nutraceuticalserectile dysfunctionL-arginineL-citrulline<i>Eruca vesicaria</i><i>Panax ginseng</i>
spellingShingle Chiara Amante
Chiara De Soricellis
Gianni Luccheo
Anna Di Vernieri
Luigi Luccheo
Giovanni Falcone
Pasquale Del Gaudio
Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5
Applied Sciences
nutraceuticals
erectile dysfunction
L-arginine
L-citrulline
<i>Eruca vesicaria</i>
<i>Panax ginseng</i>
title Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5
title_full Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5
title_fullStr Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5
title_full_unstemmed Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5
title_short Icarifil, a Natural Mixture Based on L-Citrulline and L-Carnitine as a Novel Multicomponent Nutraceutical to Modulate ROS and PDE5
title_sort icarifil a natural mixture based on l citrulline and l carnitine as a novel multicomponent nutraceutical to modulate ros and pde5
topic nutraceuticals
erectile dysfunction
L-arginine
L-citrulline
<i>Eruca vesicaria</i>
<i>Panax ginseng</i>
url https://www.mdpi.com/2076-3417/13/22/12358
work_keys_str_mv AT chiaraamante icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5
AT chiaradesoricellis icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5
AT gianniluccheo icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5
AT annadivernieri icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5
AT luigiluccheo icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5
AT giovannifalcone icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5
AT pasqualedelgaudio icarifilanaturalmixturebasedonlcitrullineandlcarnitineasanovelmulticomponentnutraceuticaltomodulaterosandpde5